We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+13.58%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62B
AUM Growth
+$4.39B
(+7.6%)
Cap. Flow
-$1.97B
Cap. Flow
% of AUM
-3.18%
Top 10 Holdings %
Top 10 Hldgs %
43.7%
Holding
1,103
New
130
Increased
284
Reduced
500
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$218M |
| 2 |
Parker-Hannifin
PH
|
+$155M |
| 3 |
Illumina
ILMN
|
+$80.7M |
| 4 |
Walt Disney
DIS
|
+$74.2M |
| 5 |
AZEK
The AZEK Co
AZEK
|
+$56.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$819M |
| 2 |
Meta Platforms (Facebook)
META
|
+$338M |
| 3 |
Microsoft
MSFT
|
+$131M |
| 4 |
Amazon
AMZN
|
+$106M |
| 5 |
Salesforce
CRM
|
+$93.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.29% |
| 2 | Communication Services | 16.35% |
| 3 | Consumer Discretionary | 16.22% |
| 4 | Healthcare | 12.62% |
| 5 | Financials | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PSTL
376
Postal Realty Trust
PSTL
$699M
| $5.17M | 0.01% |
351,610
+23,648
| +7% | +$350K |
|
|
NPKI
377
NPK International
NPKI
$1.14B
| $5.11M | 0.01% |
+976,971
| New | +$4.05M |
|
378
Procter & Gamble
PG
$339B
| $5.09M | 0.01% |
33,568
-17,184
| -34% | -$2.59M |
|
379
iShares Russell 1000 Growth ETF
IWF
$128B
| $4.99M | 0.01% |
72,532
| – | – |
|
380
Johnson & Johnson
JNJ
$625B
| $4.89M | 0.01% |
29,568
-15,396
| -34% | -$2.48M |
|
381
Embecta
EMBC
$262M
| $4.84M | 0.01% |
223,899
+32,100
| +17% | +$875K |
|
382
Coca-Cola
KO
$375B
| $4.71M | 0.01% |
78,183
-12,922
| -14% | -$804K |
|
383
Utah Medical Products
UTMD
$225M
| $4.68M | 0.01% |
50,182
-1,338
| -3% | -$126K |
|
384
Collegium Pharmaceutical
COLL
$956M
| $4.43M | 0.01% |
+206,189
| New | +$4.68M |
|
385
Lockheed Martin
LMT
$136B
| $4.43M | 0.01% |
9,618
-2,848
| -23% | -$1.32M |
|
|
NXDT
386
NexPoint Diversified Real Estate Trust
NXDT
$238M
| $4.28M | 0.01% |
341,417
| – | – |
|
387
Elevance Health
ELV
$85.5B
| $4.13M | 0.01% |
9,305
+480
| +5% | +$221K |
|
388
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $4.1M | 0.01% |
+83,211
| New | +$4.06M |
|
389
Bristol-Myers Squibb
BMY
$132B
| $3.94M | 0.01% |
61,571
+14,919
| +32% | +$1M |
|
390
American Tower
AMT
$80.4B
| $3.76M | 0.01% |
19,376
-251
| -1% | -$49.1K |
|
391
Newmont
NEM
$119B
| $3.68M | 0.01% |
86,300
+20,812
| +32% | +$945K |
|
392
Abbott
ABT
$187B
| $3.64M | 0.01% |
33,404
-5,510
| -14% | -$587K |
|
393
Walmart Inc
WMT
$890B
| $3.62M | 0.01% |
69,015
-26,541
| -28% | -$1.34M |
|
394
iShares JPMorgan EM Corporate Bond ETF
CEMB
$412M
| $3.48M | 0.01% |
80,239
+16,397
| +26% | +$711K |
|
395
Morgan Stanley
MS
$340B
| $3.28M | 0.01% |
38,404
-2,187
| -5% | -$187K |
|
396
Union Pacific
UNP
$174B
| $3.05M | ﹤0.01% |
14,892
-2,071
| -12% | -$412K |
|
397
Invesco Senior Loan ETF
BKLN
$6.74B
| $3.02M | ﹤0.01% |
143,760
| – | – |
|
398
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.1B
| $3M | ﹤0.01% |
84,851
+20,206
| +31% | +$709K |
|
399
Thermo Fisher Scientific
TMO
$220B
| $2.96M | ﹤0.01% |
5,678
-395
| -7% | -$213K |
|
400
Williams Companies
WMB
$86.1B
| $2.94M | ﹤0.01% |
90,195
-13,330
| -13% | -$400K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2023 Portfolio in Review
As of Q2 2023, Loomis, Sayles & Company held 1,103 positions worth $62B, up 7.6% from $57.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Loomis, Sayles & Company withdrew a net $1.97B in Q2 2023, closing 130 positions and reducing 500 holdings. Its most notable exit was Halozyme, an estimated $81.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Loomis, Sayles & Company opened a new position in The AZEK Co worth $66.1M.
- Loomis, Sayles & Company's largest Q2 2023 buy was The AZEK Co: 2,181,837 shares worth $66.1M.
- Loomis, Sayles & Company added most to Tesla in Q2 2023, an estimated $218M increase.
- Loomis, Sayles & Company's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $819M.
- Loomis, Sayles & Company fully exited Halozyme in Q2 2023, selling an estimated $81.3M.
- Loomis, Sayles & Company's ten largest holdings make up 44% of its $62B portfolio in Q2 2023.
- Loomis, Sayles & Company opened 130 new positions and closed 130 in Q2 2023.
- Loomis, Sayles & Company's portfolio value rose 7.6% quarter-over-quarter to $62B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.